Pharmaceutical Regulatory Affairs

Regulatory Affairs contributes essentially to the overall success of drug development, both at early pre-marketing stages and at all times post-marketing. The pharmaceutical industry deals with an increasing number of interesting drug candidates, all of which necessitate the involvement of the Regulatory Affairs’ department. Regulatory Affairs professionals can play a key role in guiding drug development strategy in an increasingly global environment. But they also play an important operational role, for example, by considering the best processes to follow and enabling structured interaction with regulatory authorities. Regulatory Affairs is driven by good science and accordingly nothing remains static.

The overall emerging markets for therapeutic drugs totaled $131.4 billion in 2009. These regions include Latin America, China, Eastern Europe, the Middle East, South Korea, India, Russia, and South Africa. These regions are estimated at $145.8 billion in 2010 and expected to continue aggressive growth through 2015, reaching a figure of $214.2 billion, yielding a compound annual growth rate (CAGR) of 8% from 2010 to 2015.

  • Regulatory & Pharmacovigilance
  • SOPs and Policy Documents
  • Clinical Affairs & Regulatory Strategies
  • Regulatory Strategies and Developments
  • Data Integrity towards Regulatory Affairs
  • Global Regulatory Intelligence
  • Regulatory Communications and Submissions
  • Regulatory Requirements for Pharmaceuticals
  • Medical Device & Combination Products Regulations
  • Best Industry Practices
  • Marketing Authorizations
  • Regulatory Challenges for Medical Devices
  • Food, drug and cosmetic laws
  • FDA and related regulatory agencies
  • Pharmacovigilance Regulations

Related Conference of Pharmaceutical Regulatory Affairs

October 23-24, 2025

21st Annual Meet on Pharmaceutical Sciences

Paris, France
November 11-12, 2025

6th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
November 13-14, 2025

21st International Conference on Pharmaceutical Chemistry

Aix-en-Provence, France
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Paris, France
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
December 30-31, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy

Pharmaceutical Regulatory Affairs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in